证券代码：603198 证券简称：迎驾贡酒 公告编号：2025-014 安徽迎驾贡酒股份有限公司 第五届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 安徽迎驾贡酒股份有限公司（以下简称"本公司"或"公司"）于 2025 年 8 月 15 日以电话、电子邮件等方式发出会议通知，并于 2025 年 8 月 25 日在公司 会议室以现场方式召开第五届监事会第八次会议。会议应到监事 5 人，实到监事 次会议的召集、召开和表决程序符合《公司法》等法律法规和《公司章程》的有 关规定，会议合法有效。 二、监事会会议审议情况 特此公告。 安徽迎驾贡酒股份有限公司监事会 表决结果：同意 5 票；反对 0 票；弃权 0 票。议案获得通过。 监事会对《公司 2025 年半年度报告全文及其摘要》进行了审核，认为： 《公 司 2025 年半年度报告全文及其摘要》的编制和审议程序符合法律法规的规定， 半年度报告的内容和格式符合中国证监会和上海证券交易所的各项规定，其所包 含的信息真实、准确、完整地 ...

一、取消监事会情况 为进一步提高公司治理水平，促进公司规范运作，根据《中华人民共和国公 司法》及中国证监会于2025年3月最新发布的《上市公司章程指引》等相关法律、 法规和规范性文件的规定，结合公司实际情况，公司拟取消监事会，由董事会审 计委员会行使《公司法》规定的监事会的职权，并相应修订《公司章程》及附件 股票代码：600376 股票简称：首开股份 编号：临2025-066 北京首都开发股份有限公司 关于取消监事会并修订《公司章程》 及公司部分管理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 北京首都开发股份有限公司（以下简称"首开股份"、"公司"或"本公司"） 于2025年8月25日召开了第十届董事会第四十七次会议、第十届监事会第十四次 会议，审议通过了《关于取消监事会并修订 <公司章程> 及其附件的议案》，该 议案尚需提请公司2025年第四次临时股东会审议。现将相关事项公告如下： 《股东会议事规则》《董事会议事规则》，同时废止《监事会议事规则》。 公司现任监事履职至本次新修订的《公司章程》经公司股东会审议通 ...

Group 1 - The board meeting of Yijiahe Technology Co., Ltd. was held on August 25, 2025, with all six directors present, including three who attended via telecommunication [1][2] - The meeting reviewed and approved the company's 2025 semi-annual report and its summary, with a unanimous vote of 6 in favor [2] - The board also approved a special report on the storage and actual use of raised funds for the first half of 2025, again with a unanimous vote of 6 in favor [2] - The board decided to revise certain company regulations to enhance governance and compliance with relevant laws and regulations, with all votes in favor [2]

Group 1 - The board of directors of Ningbo Fujia Industrial Co., Ltd. held its fifth meeting of the third session, where all nine directors attended, ensuring the meeting's legality and validity [1] - The board approved the 2025 semi-annual report and its summary, which was reviewed by the audit committee [2] - The board decided to cancel the supervisory board and amend the company's articles of association, transferring the supervisory powers to the audit committee [2][3] Group 2 - The board approved the formulation, revision, and abolition of certain corporate governance systems to comply with the latest legal requirements [3][4] - The board proposed to hold the first extraordinary general meeting of shareholders in 2025 on September 12, 2025 [5]

Group 1: Board Meeting Overview - The third meeting of the third board of directors of Suzhou Weichuang Electric Technology Co., Ltd. was held on August 25, 2025, with all six directors present, ensuring compliance with relevant laws and regulations [1] - The board approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's financial status as of June 30, 2025 [1][2] Group 2: Fund Management and Usage - The board approved a special report on the management and actual usage of raised funds for the first half of 2025, confirming compliance with relevant regulations and that funds were stored in dedicated accounts and used appropriately [2][3] Group 3: Profit Distribution and Capital Changes - The board approved a profit distribution plan for the first half of 2025, proposing a cash dividend of 1.50 yuan per 10 shares, which considers the company's profitability and cash flow [3][4] - The board approved a proposal to change the company's registered capital, increasing it from 211,375,274 yuan to 213,794,774 yuan due to stock incentive plan activities [4][5] Group 4: Governance and Incentive Plans - The board approved the formulation and revision of certain corporate governance systems to enhance operational standards [5][6] - The board approved the draft of the 2025 stock option incentive plan, aimed at attracting and retaining talent while aligning the interests of shareholders, the company, and employees [6][7] - The board approved the management measures for the implementation of the 2025 stock option incentive plan to ensure its successful execution [8] Group 5: Shareholder Meeting and Authorizations - The board proposed to convene the first temporary shareholders' meeting of 2025 on September 10, 2025, to discuss various matters [10] - The board sought authorization from the shareholders to handle matters related to the 2025 stock option incentive plan, including determining eligibility and managing the plan's execution [9][10]

General Principles - The rules are established to improve the corporate governance structure of Shenzhen QY Optoelectronics Co., Ltd. and ensure the board of directors exercises decision-making power legally, scientifically, and efficiently [1][2] - The rules are based on relevant laws, regulations, and the company's articles of association [1] Composition and Responsibilities of the Board - The board consists of eleven directors, including one chairman, two vice-chairmen, and one employee representative director, with independent directors making up at least one-third of the board [2] - The board has various powers, including convening shareholder meetings, executing shareholder resolutions, deciding on business plans and investment proposals, and managing internal structures [2][3][4] Board Meeting Procedures - The board must meet at least twice a year, with meetings convened by the chairman [16] - A temporary meeting can be proposed by shareholders or directors, requiring a notice period of three days unless urgent [16][18] - Decisions require a majority of directors present, and independent directors must attend personally or provide written opinions if absent [17][18] Voting and Decision-Making - Board resolutions are made through a voting process, requiring a majority approval from all directors [35][36] - Directors with conflicts of interest must abstain from voting on related matters [19][20] Committees - The board establishes specialized committees, including audit, nomination, compensation, and strategy committees, with independent directors holding a majority in certain committees [6][7] - Each committee is responsible for specific tasks, such as reviewing financial information, proposing director candidates, and evaluating executive compensation [6][7] Director Qualifications and Duties - Directors must be natural persons and cannot hold positions if they have certain legal or financial disqualifications [8][9] - Directors have fiduciary duties to act in the best interest of the company, avoid conflicts of interest, and maintain confidentiality [11][12][13] Amendments and Effectiveness - The rules will take effect upon approval by the shareholders and will be updated as necessary to comply with new laws or regulations [46][47]

Core Points - The articles outline the regulations and governance structure of Zhejiang Hisun Pharmaceutical Co., Ltd, emphasizing the protection of the rights of shareholders, employees, and creditors [1][3][4] - The company is established as a publicly listed joint-stock company with a registered capital of RMB 1,198.848196 million [2][7] - The company aims to be a leading pharmaceutical enterprise focusing on research and innovation, adhering to high production standards [5][6] Group 1: General Provisions - The company is established under the Company Law and other relevant regulations, with its legal representative being the chairman elected by the board [1][2] - The company has a permanent existence as a publicly listed joint-stock company [2] - The articles serve as a legally binding document governing the relationships and rights among the company, shareholders, and management [3][4] Group 2: Business Objectives and Scope - The company's business objective is to provide high-quality pharmaceutical products and health solutions globally, driven by research and innovation [5] - The business scope includes drug production, pharmaceutical wholesale, and various related activities, subject to legal approvals [5][6] Group 3: Shares - The company issues shares in the form of stocks, ensuring equal rights for all shares of the same category [7][8] - The total number of issued shares is 1,198,481,196, all of which are ordinary shares [7][8] - The company can provide financial assistance for acquiring its shares under specific conditions approved by the board [8][9] Group 4: Shareholder Rights and Meetings - Shareholders have rights to dividends, voting, and participation in company decisions, with equal rights for shares of the same category [14][15] - The company must hold annual and extraordinary shareholder meetings, with specific procedures for calling and conducting these meetings [48][49] - Shareholder proposals must be submitted within a specified timeframe before meetings, ensuring transparency and participation [58][59]

Core Viewpoint - The Shandong Pharmaceutical Glass Co., Ltd. is holding its first extraordinary general meeting of shareholders in 2025 to discuss significant governance changes, including the abolition of the supervisory board and amendments to the company's articles of association and meeting rules [1][2][4]. Meeting Details - The meeting will take place on September 12, 2025, at 15:00, with both on-site and online voting options available for shareholders [1][2]. - The location of the meeting is the R&D building of Shandong Pharmaceutical Glass Co., Ltd. in Yiyuan County, Zibo City, Shandong Province [2]. Agenda Items - **Proposal 1**: Abolishment of the supervisory board and the corresponding rules, transferring its powers to the audit committee of the board of directors, ensuring compliance with updated regulations [2][4]. - **Proposal 2**: Amendments to the company's articles of association to enhance governance structure and operational standards, in line with the latest regulatory requirements [4][5]. - **Proposal 3**: Revisions to the rules governing shareholder meetings to align with the adjustments in governance structure and regulatory compliance [5][6]. - **Proposal 4**: Updates to the rules governing board meetings to ensure continued adherence to regulatory standards and improve governance practices [6][7].

Core Viewpoint - Shanghai Zhongchen Electronic Technology Co., Ltd. is canceling its supervisory board and revising its articles of association to enhance corporate governance and comply with new legal requirements [1][2]. Group 1: Cancellation of Supervisory Board - The company has decided to abolish the supervisory board to align with the latest legal regulations effective from July 1, 2024, including the Company Law of the People's Republic of China and relevant guidelines [1][2]. - The responsibilities of the supervisory board will be transferred to the audit committee of the board of directors [1]. Group 2: Revision of Articles of Association - The company is revising its articles of association to reflect changes in governance structure, including the addition of employee representative directors [2][3]. - Key revisions include: - The legal representative of the company will be the chairman, and if the chairman resigns, a new representative must be appointed within 30 days [2]. - The articles will now specify that the company bears civil liability for actions taken by the legal representative in the course of their duties [3][4]. - The revised articles will have legal binding force on the company, shareholders, directors, and senior management [4][5]. Group 3: Shareholder Rights and Responsibilities - Shareholders are entitled to various rights, including profit distribution and the ability to request meetings and participate in decision-making [16][17]. - The company emphasizes that shareholders must comply with legal obligations and cannot abuse their rights to harm the company or other shareholders [21][22].

Group 1 - The board of directors of Ningbo Hongxun Technology Co., Ltd. held its second meeting of 2025, with all 9 directors present, confirming compliance with relevant laws and regulations [1][2] - The board approved the proposal to abolish the supervisory board, transferring its responsibilities to the audit committee, and agreed to amend the company's articles of association accordingly [2][3] - The proposal to amend the articles of association and related governance documents will be submitted to the shareholders' meeting for approval [2][3] Group 2 - The voting results for the proposals were unanimous, with 9 votes in favor and no votes against or abstentions [2][3] - The company will authorize the management team to handle all matters related to the changes resulting from the abolishment of the supervisory board [2]